Statements (23)
Predicate | Object |
---|---|
gptkbp:instanceOf |
gptkb:company
|
gptkbp:acquiredBy |
gptkb:Pfizer
|
gptkbp:acquisitionYear |
2015
|
gptkbp:CEO |
gptkb:F._Michael_Ball
|
gptkbp:country |
gptkb:United_States
|
gptkbp:founded |
2004
spin-off from Abbott Laboratories |
gptkbp:headquartersLocation |
gptkb:Lake_Forest,_Illinois,_United_States
|
https://www.w3.org/2000/01/rdf-schema#label |
Hospira
|
gptkbp:industry |
pharmaceuticals
|
gptkbp:notableProduct |
gptkb:GemStar_infusion_system
gptkb:Precedex gptkb:Propofol |
gptkbp:numberOfEmployees |
approximately 19,000 (2015)
|
gptkbp:parentCompany |
gptkb:Pfizer
|
gptkbp:products |
biosimilars
generic injectable pharmaceuticals infusion technologies |
gptkbp:stockSymbol |
gptkb:HSP
|
gptkbp:tradedOn |
gptkb:NYSE
|
gptkbp:website |
www.hospira.com
|
gptkbp:bfsParent |
gptkb:Pfizer
|
gptkbp:bfsLayer |
4
|